Market Research Logo

Breast Cancer Liquid Biopsy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

Breast Cancer Liquid Biopsy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

The report on the global breast cancer liquid biopsy market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global breast cancer liquid biopsy market to grow with a CAGR of 20.9% over the forecast period from 2018-2024. The study on breast cancer liquid biopsy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on breast cancer liquid biopsy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global breast cancer liquid biopsy market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global breast cancer liquid biopsy market over the period of 2016 to 2024. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• Increasing incidence of breast cancer
• Increasing preference for noninvasive breast cancer procedure
2) Restraints
• Costly treatment procedure
• Lack of trained health care professionals
3) Opportunities
• Government initiative for the eradication of breast cancer

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global breast cancer liquid biopsy market is segmented on the basis of biomarker, and end-user.

The Global Breast Cancer Liquid Biopsy Market by Biomarker
• Extracellular Vesicles (EVs)
• Cell-free DNA (cfDNA)
• Circulating Tumor Cells (CTCs)
• Other Circulating Biomarkers

The Global Breast Cancer Liquid Biopsy Market by End-User
• Hospitals And Physician Laboratories
• Reference Laboratories
• Other

Company Profiles
The companies covered in the report include
• Isogen Life Science
• GUARDANT HEALTH, INC
• Biodesix, Inc.
• FLUXION BIOSCIENCES
• Thermo Fisher Scientific Inc.
• Genomic Health
• Cynvenio Biosystems, Inc.
• Illumina, Inc.
• Menarini Silicon Biosystems
• Myriad Genetics, Inc.

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the breast cancer liquid biopsy market.
2. Complete coverage of all the segments in the breast cancer liquid biopsy market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global breast cancer liquid biopsy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on breast cancer liquid biopsy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global breast cancer liquid biopsy market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Breast Cancer Liquid Biopsy Market Highlights
2.2. Breast Cancer Liquid Biopsy Market Projection
2.3. Breast Cancer Liquid Biopsy Market Regional Highlights
3. Global Breast Cancer Liquid Biopsy Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Biomarker
3.4.2. IGR-Growth Matrix Analysis by End-User
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Breast Cancer Liquid Biopsy Market
4. Breast Cancer Liquid Biopsy Market Macro Indicator Analysis
5. Global Breast Cancer Liquid Biopsy Market by Biomarker
5.1. Extracellular Vesicles (EVs)
5.2. Cell-free DNA (cfDNA)
5.3. Circulating Tumor Cells (CTCs)
5.4. Other Circulating Biomarkers
6. Global Breast Cancer Liquid Biopsy Market by End-User
6.1. Hospitals and Physician Laboratories
6.2. Reference Laboratories
6.3. Other
7. Global Breast Cancer Liquid Biopsy Market by Region 2018-2024
7.1. North America
7.1.1. North America Breast Cancer Liquid Biopsy Market by Biomarker
7.1.2. North America Breast Cancer Liquid Biopsy Market by End-User
7.1.3. North America Breast Cancer Liquid Biopsy Market by Country
7.2. Europe
7.2.1. Europe Breast Cancer Liquid Biopsy Market by Biomarker
7.2.2. Europe Breast Cancer Liquid Biopsy Market by End-User
7.2.3. Europe Breast Cancer Liquid Biopsy Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Breast Cancer Liquid Biopsy Market by Biomarker
7.3.2. Asia-Pacific Breast Cancer Liquid Biopsy Market by End-User
7.3.3. Asia-Pacific Breast Cancer Liquid Biopsy Market by Country
7.4. RoW
7.4.1. RoW Breast Cancer Liquid Biopsy Market by Biomarker
7.4.2. RoW Breast Cancer Liquid Biopsy Market by End-User
7.4.3. RoW Breast Cancer Liquid Biopsy Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Breast Cancer Liquid Biopsy Market
8.2. Companies Profiles
8.2.1. Isogen Life Science
8.2.2. GUARDANT HEALTH, INC
8.2.3. Biodesix, Inc.
8.2.4. FLUXION BIOSCIENCES
8.2.5. Thermo Fisher Scientific Inc.
8.2.6. Genomic Health
8.2.7. Cynvenio Biosystems, Inc.
8.2.8. Illumina, Inc.
8.2.9. Menarini Silicon Biosystems
8.2.10. Myriad Genetics, Inc.
9. Appendix
9.1. Primary Research Findings and Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report